Regenxbio trumpets one-year data for Hunter syndrome gene therapy after FDA extended its reviewnews2025-09-05T14:14:19+00:00September 5th, 2025|Endpoints News|
CDER and CBER offer new submission program for rare disease gene therapiesnews2025-09-03T15:41:24+00:00September 3rd, 2025|Endpoints News|
Exclusive: Mytos inks cell therapy manufacturing deals with three European biotechs news2025-09-03T07:00:17+00:00September 3rd, 2025|Endpoints News|
Vertex enlists Enlaza for gene therapy conditioning and autoimmune disease pactnews2025-09-02T15:34:54+00:00September 2nd, 2025|Endpoints News|
Wugen collects $115M as it runs pivotal allogeneic CAR-T trialnews2025-08-27T11:00:58+00:00August 27th, 2025|Endpoints News|
FDA lifts hold on Rocket’s pivotal study for its gene therapy, which is now a lower dosenews2025-08-20T14:59:39+00:00August 20th, 2025|Endpoints News|
Catalent lays off 350 workers over change in demand from a ‘large customer’ news2025-08-20T11:20:59+00:00August 20th, 2025|Endpoints News|
Genentech ends up to $2B cell therapy collab with Adaptivenews2025-08-18T15:33:05+00:00August 18th, 2025|Endpoints News|
Anocca gets $46M to run early TCR cell therapy clinical trialnews2025-08-18T07:00:20+00:00August 18th, 2025|Endpoints News|
Gene therapy startup Kriya Therapeutics gets $313Mnews2025-08-15T20:58:52+00:00August 15th, 2025|Endpoints News|
